leisure time -WSS

leisure time

author：entertainment 2025-09-06 04:17:33 - browse：11639

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Cue Health, Covid

WSS

Why 40% Americans with Parkinson’s don’t see a neurologist

H5N1 virus can be tracked in retail milk, scientists say

Oak trusses raised to roof of fire

N.Y. state detects polio case, first in the U.S. since 2013

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

New research casts further doubt on a common procedure used with IVF

entertainment

leisure time

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

A new study sees potential in DNA sequencing of infants

New air purifier tech could be key to improving indoor air quality

Questions and answers about ramping up H5N1 bird flu vaccine

Medicare proposal to cover medical devices draws a mixed reaction

Bird flu surveillance in wastewater gets boost from consortium

Activists slam private health insurers over coverage restrictions

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Psychedelics group wrestles with new pharma identity

Citing H5N1 threat, CDC urges peak flu monitoring this summer

hotspot

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

H5N1 bird flu outbreak: Second human case reported, in Michigan

California’s proposed $25 per hour health care minimum wage

Listen: More tumult at BIO & coercive care for sickle cell patients

H5N1 virus can be tracked in retail milk, scientists say

Listen: A conversation with researcher Kevin Esvelt on biosecurity

leisure time

focus

knowledge

leisure time